Login / Signup

Response to BRAF and MEK Inhibitors in BRAF Thr599dup-Mutated Melanoma.

Marion OberléPhilippe JammeSandrine MansardLaurent MachetAlice HervieuNora KramkimelAnna GreliakAnne Sophie JarrousseValentin DerangèreDavid DudoignonClotilde DescarpentriesLaurent Mortier
Published in: JCO precision oncology (2022)
Keyphrases
  • wild type
  • metastatic colorectal cancer
  • pi k akt
  • skin cancer
  • cell proliferation